OneMedNet Expands Partnership with Atropos Health for Clinical Data Access

OneMedNet Corporation, a provider of direct-from-source, regulatory-grade clinical data, has announced a three-year subscription agreement with Atropos Health to access its extensive medical records platform. The partnership aims to integrate OneMedNet’s de-identified imaging and multimodal clinical data—spanning over 90 million patient journeys across 2,300 sites—into Atropos’ platform. This collaboration also leverages OneMedNet’s broader network of over 270 million studies, offering richer datasets for health systems, life sciences firms, researchers, medical device manufacturers, and AI developers. The deal is structured as a subscription-based license, contributing to OneMedNet’s annual recurring revenue by enabling Atropos to process and analyze high-quality, evidence-based medical information. Aaron Green, president and CEO of OneMedNet, emphasized the partnership’s alignment with the company’s strategy of transforming its data into long-term, collaborative subscriptions. Dr. Brigham Hyde, CEO and co-founder of Atropos Health, noted that the partnership will enhance the depth of insights available to Atropos’ clients, addressing critical gaps in medical evidence through the integration of regulatory-grade imaging and clinical records. The agreement was announced on September 22, 2026, reflecting a growing trend in healthcare data monetization and AI-driven medical research.